Novozymes, Inc. | Novo Holdings A/S | United States | federal | 2008 | $9,994,970 | | federal grant |
Amyris, Inc. | Amyris | United States | federal | 2009 | $24,341,409 | | federal grant |
Novozymes, Inc. | Novo Holdings A/S | United States | federal | 2013 | $2,500,000 | | federal grant |
Amyris, Inc. | Amyris | United States | federal | 2016 | $3,549,805 | | federal grant |
Novozymes North America, Inc. | Novo Holdings A/S | United States | federal | 2011 | $1,568,670 | | federal grant |
Novozymes Blair, Inc. | Novo Holdings A/S | United States | federal | 2010 | $28,401,000 | | federal allocated tax credit |
Fort Dodge Laboratories, Inc. | Zoetis | Iowa | state | 2007 | $2,617,500 | | enterprise zone |
Abraxis BioScience | Bristol-Myers Squibb | Iowa | state | 2008 | $662,500 | | enterprise zone |
Dr. Reddys Laboratories Louisiana LLC | Dr. Reddy's Laboratories | Louisiana | state | 2010 | $101,000 | | Enterprise zone |
IDEXX Distribution Inc | IDEXX Laboratories | Maine | state | 2010 | undisclosed | | enterprise zone |
IDEXX Operations Inc | IDEXX Laboratories | Maine | state | 2010 | undisclosed | | enterprise zone |
IDEXX Laboratories, Inc. | IDEXX Laboratories | Maine | state | 2010 | undisclosed | | enterprise zone |
SYNTHES (U.S.A.) | Johnson & Johnson | New York | state | 2006 | $2,697,365 | | enterprise zone |
Bausch & Lomb Incorporated | Bausch Health | New York | state | 2006 | $1,599,567 | | enterprise zone |
Regeneron Pharmaceuticals Inc. | Regeneron Pharmaceuticals | New York | state | 2006 | $200,144 | | enterprise zone |
Clay-Park Labs Inc. | Perrigo | New York | state | 2006 | $150,000 | | enterprise zone |
SYNTHES (U.S.A.) | Johnson & Johnson | New York | state | 2007 | $2,870,000 | | enterprise zone |
Bausch & Lomb Incorporated | Bausch Health | New York | state | 2007 | $1,123,304 | | enterprise zone |
Regeneron Pharmaceuticals Inc. | Regeneron Pharmaceuticals | New York | state | 2007 | $416,897 | | enterprise zone |
BEN VENUE LABORATORIES | Boehringer Ingelheim | Ohio | state | 2001 | $2,439,160 | | enterprise zone |
BEN VENUE LABORATORIES, INC. | Boehringer Ingelheim | Ohio | state | 2005 | $2,246,703 | | enterprise zone |
BEN VENUE LABORATORIES, INC. | Boehringer Ingelheim | Ohio | state | 2006 | undisclosed | | enterprise zone |
BEN VENUE LABORATORIES | Boehringer Ingelheim | Ohio | state | 2007 | undisclosed | | enterprise zone |
PharmaForce, Inc. | Daiichi Sankyo | Ohio | state | 2008 | undisclosed | | enterprise zone |
CSL Plasma, Inc. | CSL Limited | Arizona | state | 2010 | undisclosed | | enterprise zone |
CSL Plasma, Inc. | CSL Limited | Arizona | state | 2010 | undisclosed | | enterprise zone |
Cangene bioPharma, Inc. | Emergent BioSolutions | Maryland | local | 2009 | undisclosed | | enterprise zone |
Boehringer Ingelheim Roxane, Inc./Roxane Laboratories, Inc. | Hikma Pharmaceuticals | Ohio | state | 2012 | undisclosed | | enterprise zone |
ETHICON, INC. | Johnson & Johnson | Texas | state | 2002 | undisclosed | | enterprise zone |
ETHICON, INC. | Johnson & Johnson | Texas | state | 2002 | undisclosed | | enterprise zone |
ETHICON, INC. | Johnson & Johnson | Texas | state | 2003 | undisclosed | | enterprise zone |
ETHICON INC | Johnson & Johnson | Texas | state | 2002 | undisclosed | | enterprise zone |
IDEXX Distribution Inc | IDEXX Laboratories | Maine | state | 2012 | undisclosed | | enterprise zone |
IDEXX Laboratories, Inc. | IDEXX Laboratories | Maine | state | 2017 | undisclosed | | enterprise zone |
IDEXX Operations Inc | IDEXX Laboratories | Maine | state | 2012 | undisclosed | | enterprise zone |
IDEXX Reference Laboratories, Inc | IDEXX Laboratories | Maine | state | 2012 | undisclosed | | enterprise zone |
Albany Molecular Research, Inc. | Curia Inc. | New York | state | 2003 | $8,249 | | enterprise zone |
Albany Molecular Research, Inc. | Curia Inc. | New York | state | 2001 | $944,526 | | enterprise zone |
Albany Molecular Research, Inc. | Curia Inc. | New York | state | 2002 | $95,858 | | enterprise zone |
Albany Molecular Research, Inc. | Curia Inc. | New York | state | 2003 | $5,679,250 | | enterprise zone |
Albany Molecular Research, Inc. | Curia Inc. | New York | state | 2011 | $54,000 | | enterprise zone |
Albany Molecular Research, Inc. | Curia Inc. | New York | state | 2012 | $191,566 | | enterprise zone |
Albany Molecular Research, Inc. | Curia Inc. | New York | state | 2013 | $191,000 | | enterprise zone |
Albany Molecular Research, Inc. | Curia Inc. | New York | state | 2014 | $63,126 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2008 | $290,648 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2008 | $290,648 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2009 | $877,386 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2009 | $877,386 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2010 | $794,527 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2010 | $794,527 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2010 | $1,951,103 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2011 | $316,824 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2011 | $1,107,208 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2011 | $1,107,208 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2012 | $372,801 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2012 | $1,515,349 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2012 | $1,515,349 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2013 | $197,815 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2013 | $914,531 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2013 | $914,531 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2014 | $207,247 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2014 | $5,509,471 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2014 | $5,509,471 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2015 | $95,771 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2015 | $4,151,414 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2015 | $4,151,414 | | enterprise zone |
AMRI Rensselaer, Inc. | Curia Inc. | New York | state | 2009 | $538,000 | | enterprise zone |
AMRI Rensselaer, Inc. | Curia Inc. | New York | state | 2010 | $119,000 | | enterprise zone |
AMRI Rensselaer, Inc. | Curia Inc. | New York | state | 2008 | $353,143 | | enterprise zone |
AMRI Rensselaer, Inc. | Curia Inc. | New York | state | 2011 | $363,000 | | enterprise zone |
AMRI Rensselaer, Inc. | Curia Inc. | New York | state | 2012 | $390,683 | | enterprise zone |
AMRI Rensselaer, Inc. | Curia Inc. | New York | state | 2013 | $333,000 | | enterprise zone |
AMRI Rensselaer, Inc. | Curia Inc. | New York | state | 2014 | $764,142 | | enterprise zone |
AMRI Rensselaer, Inc. | Curia Inc. | New York | state | 2015 | $34,827 | | enterprise zone |
Bausch & Lomb Incorporated | Bausch Health | New York | state | 2009 | $1,169,891 | | enterprise zone |
Bausch & Lomb Incorporated | Bausch Health | New York | state | 2010 | $1,517,457 | | enterprise zone |
Bausch & Lomb Incorporated | Bausch Health | New York | state | 2005 | $680,000 | | enterprise zone |
Bausch & Lomb Incorporated | Bausch Health | New York | state | 2008 | $1,187,088 | | enterprise zone |
Bausch & Lomb Incorporated | Bausch Health | New York | state | 2011 | $1,490,125 | | enterprise zone |
Bausch & Lomb Incorporated | Bausch Health | New York | state | 2012 | $1,416,700 | | enterprise zone |
Bausch & Lomb Incorporated | Bausch Health | New York | state | 2013 | $375,037 | | enterprise zone |
Bristol-Myers Squibb Company, Inc. | Bristol-Myers Squibb | New York | state | 2002 | $275,000 | | enterprise zone |
Clay-Park Labs, Inc. | Perrigo | New York | state | 2004 | $17,000 | | enterprise zone |
Clay-Park Labs, Inc. | Perrigo | New York | state | 2005 | $57,000 | | enterprise zone |
Clay-Park Labs, Inc. | Perrigo | New York | state | 2008 | $5,666 | | enterprise zone |
Clay-Park Labs, Inc. | Perrigo | New York | state | 2003 | $257,000 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2008 | $1,274,849 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2008 | $1,274,849 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2008 | $1,274,849 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2009 | $453,858 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2009 | $453,858 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2009 | $453,858 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2010 | $753,841 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2010 | $753,841 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2010 | $753,841 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2011 | $698,828 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2011 | $698,828 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2011 | $698,828 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2012 | $92,277 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2012 | $92,277 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2012 | $92,277 | | enterprise zone |